Outcomes and Patterns Related to Magnesium in Acute Heart Failure: A Population-Based Study
Margaryan, R.; Islam, S.; Dover, D. C.; McAlister, F.; Kaul, P.; Ezekowitz, J. A.
Show abstract
ImportanceThe significance of magnesium as a treatment or prognostic factor is unknown in heart failure despite its frequent use. ObjectiveTo assess the frequency and outcomes of magnesium testing, hypomagnesemia and intravenous (IV) replacement in a large population-based cohort. Design, Setting, and ParticipantsRetrospective cohort study using linked administrative data from April 2012 - March 2020. Patients with primary diagnosis of HF in the emergency department or hospital were included and the rates and outcomes of magnesium testing, hypomagnesemia and IV replacement were assessed. Main Outcome(s) and Measure(s)The primary clinical outcomes included all-cause and cause specific death and hospitalization. Secondary outcomes included emergency department visits and physicians claims. Other outcomes included factors and rates of serum magnesium testing and hypomagnesemia. ResultsOf 78,957 acute heart failure episodes (in 42,763 patients), 58.7% included a serum magnesium measurement. Of the patients who were tested, serum magnesium levels were <0.75 mmol/L in 31.7%, between 0.75 - 0.95 mmol/L in 56.8% and >0.95 mmol/L in 11.5%. Magnesium levels (per 0.02 mmol/L increase) were independently associated with mortality when <0.70 mmol/L [hazard ratio (HR) 0.99 (95% confidence interval (CI) 0.98-0.99); p<0.001] or >0.86 mmol/L [HR 1.04 (95% CI 1.03-1.04); p<0.001]. IV magnesium was given to 13.7% (n=6,333) of those who were tested (29.7% of whom did not have hypomagnesemia); after multivariable adjustment, receiving IV magnesium was associated with a higher short term mortality [HR 1.66 (95% CI 1.4-1.96); p<0.0001] and hospitalization risk [HR 1.36 (95% CI 1.13-1.63); p<0.001]. Conclusions and RelevanceSerum magnesium testing is common in patients presenting to the ED or hospital with HF, and low or high magnesium is associated with worse outcomes. Replacement with IV magnesium was associated with worse outcomes even after adjustment, a finding which warrants further study.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions 95%
- Prognostic value of compact myocardial thinning in patients with left ventricular non-compaction 93%
- Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction 93%
Similar papers in this journal
- Multispecialty multidisciplinary input into comorbidities in heart failure reduces hospitalisation and clinic attendance 94%
- Vascular Comorbidities Worsen Prognosis of Patients with Heart Failure Hospitalized with COVID-19 94%
- Cardiac Post-acute Sequelae symptoms of SARS-CoV-2 in Community-Dwelling Adults: Cross-sectional Study 92%
Similar papers in this journal
- Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator 94%
- National Trends and Disparities in Hospitalization for Hypertensive Emergencies Among Medicare Beneficiaries, 1999–2019 93%
- Aptamer Proteomics for Biomarker Discovery in Heart Failure with Reduced Ejection Fraction 93%
Similar papers in this journal
- High Variability of Body Mass Index Independently Associated with Incident Heart Failure 94%
- An International Longitudinal Natural History Study of Danon Disease Patients: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes 94%
- Carotid Intima-media thickness, carotid distensibility and incident heart failure in older men: The British Regional Heart Study 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.